Trial intelligence / Profile preview

Viena II in Hypertension and Dyslipidemia

NCT03401580Phase 2Withdrawn

Sponsor
EMS
Start
Jan 2019
Primary completion
Jul 2019
01

Overview

A Phase 2 trial of Viena II in hypertension (HTN), dyslipidemia, sponsored by EMS. Planned start Jan 2019; status: withdrawn.

02

Drugs

Viena II
03

Conditions

hypertension (HTN)dyslipidemia

Beyond the preview

Go deeper on NCT03401580.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03401580.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call